New data from the BIG 1-98 breast cancer trial

Bookmark and Share
Published: 23 Dec 2008
Views: 17474
Rating:
Save
Professor Henning Mouridsen, Copenhagen University Hospital
Professor Mouridsen, the BIG 1-98 Lead Investigator at Copenhagen University Hospital, discusses findings and new data from the BIG 1-98 breast cancer trial, announced at the 31st San Antonio Breast Cancer Symposium. "Post menopausal patients with primary hormone receptor positive disease should now be offered up front letrozole rather than tamoxifen"